The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Polushkina T.V.

Lomonosov Moscow State University, Medical Research and Educational Institute;
I.V. Davydovsky City Clinical Hospital

Kalinin D.V.

Lomonosov Moscow State University, Medical Research and Educational Institute;
A.V. Vishnevsky National Medical Research Center of Surgery

Danilova N.V.

Lomonosov Moscow State University, Medical Research and Educational Institute;
Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery

Correlation of tumor budding with DNA mismatch repair system and PD-L1-status in gastric cancer

Authors:

Polushkina T.V., Kalinin D.V., Danilova N.V.

More about the authors

Read: 417 times


To cite this article:

Polushkina TV, Kalinin DV, Danilova NV. Correlation of tumor budding with DNA mismatch repair system and PD-L1-status in gastric cancer. Russian Journal of Archive of Pathology. 2025;87(4):5‑12. (In Russ.)
https://doi.org/10.17116/patol2025870415

Recommended articles:
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
Frequency of MSI, PD-L1 (CPS), HER2 in poorly cohe­sive gastric carcinomas. Russian Journal of Archive of Pathology. 2025;(2):11-17
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139

References:

  1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.  https://doi.org/10.3322/caac.21834
  2. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. Zlokachestvennye novoobrazovaniya v Rossii v 2023 godu (zabolevaemost’ i smertnost’). M.: MNIOI im. P.A. Gertsena — filial FGBU «NMITs radiologii» Minzdrava Rossii; 2024. 276p. (In Russ,).
  3. Wittekind C. The development of the TNM classification of gastric cancer. Pathol Int. 2015;65(8):399-403.  https://doi.org/10.1111/pin.12306
  4. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-648.  https://doi.org/10.1016/S0140-6736(20)31288-5
  5. Jass JR, Barker M, Fraser L, Walsh MD, Whitehall VL, Gabrielli B, Young J, Leggett BA. APC mutation and tumour budding in colorectal cancer. J Clin Pathol. 2003;56(1):69-73.  https://doi.org/10.1136/jcp.56.1.69
  6. Topal U, Gülcan P, Yüksel S, Teke Z, Bektaş H, Duman M. The relationship between microsatellite instability in colorectal adenocarcinoma and tumor budding and histopathological parameters. Eur Rev Med Pharmacol Sci. 2023;27(20):9793-9800. https://doi.org/10.26355/eurrev_202310_34154
  7. Hacking S, Sajjan S, Angert M, Ebare K, Jin C, Chavarria H, Kataria N, Zhang L, Cho M, Thomas R, et al. Tumor budding in colorectal carcinoma showing a paradoxical mitotic index (via PHH3) with possible association to the tumor stromal microenvironment. Appl Immunohistochem Mol Morphol. 2020;28(8):627-634.  https://doi.org/10.1097/PAI.0000000000000805
  8. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med. 2006;203(4):883-895.  https://doi.org/10.1084/jem.20051776
  9. Korehisa S, Oki E, Iimori M, Nakaji Y, Shimokawa M, Saeki H, Okano S, Oda Y, Maehara Y. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability. Int J Cancer. 2018;142(4):822-832.  https://doi.org/10.1002/ijc.31107
  10. Kim JH, Park HE, Cho NY, Lee HS, Kang GH. Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers. Br J Cancer. 2016;115(4):490-496.  https://doi.org/10.1038/bjc.2016.211
  11. Secinti IE, Ozgur T, Dede I. PD-L1 expression in colorectal adenocarcinoma is associated with the tumor immune microenvironment and epithelial-mesenchymal transition. Am J Clin Pathol. 2022;158(4):506-515.  https://doi.org/10.1093/ajcp/aqac077
  12. Ulase D, Heckl S, Behrens HM, Krüger S, Röcken C. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference. Histopathology. 2020;76(3):433-446.  https://doi.org/10.1111/his.13997
  13. Zhang N, Wang D, Duan Y, Ayarick VA, Cao M, Wang Y, Zhang G, Wang Y. The special immune microenvironment of tumor budding and its impact on prognosis in gastric adenocarcinoma. Pathol Res Pract. 2020;216(6):152926. https://doi.org/10.1016/j.prp.2020.152926
  14. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127(2):385-394.  https://doi.org/10.1053/j.gastro.2004.04.022
  15. Wang LM, Kevans D, Mulcahy H, O’Sullivan J, Fennelly D, Hyland J, O’Donoghue D, Sheahan K. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol. 2009;33(1):134-141.  https://doi.org/10.1097/PAS.0b013e318184cd55
  16. Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B, Lugli A. Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer. 2013;49(5):1032-1039. https://doi.org/10.1016/j.ejca.2012.10.022

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.